Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Elizabeth R. Tucker,Irène Jiménez,Lindi Chen,Angela Bellini,Chiara Gorrini,Elizabeth Calton,Qiong Gao, Harvey Che,Evon Poon,Yann Jamin,Barbara Martins Da Costa,Karen Barker, Sumana Shrestha,J. Ciaran Hutchinson, Simran Dhariwal, Angharad Goodman,Elaine Del Nery,Pierre Gestraud,Jaydutt Bhalshankar,Yasmine Iddir, Elnaz Saberi-Ansari,Alexandra Saint-Charles,Birgit Geoerger,Maria Eugénia Marques Da Costa,Cécile Pierre-Eugène,Isabelle Janoueix‐Lerosey,Didier Decaudin,Fariba Némati,Ángel M. Carcaboso,Didier Surdez,Olivier Delattre,Sally L. George,Louis Chesler,Deborah A. Tweddle,Gudrun Schleiermacher openalex（2023）
摘要
Cell line growth curves and PDX data for idasanutlin combination
查看译文
AI 理解论文
溯源树
样例
